APR 6·BitgetHigh
Investment bank Leerink Partners recently released a research report, initiating coverage on biotechnology company Satellos Bioscience Inc. (stock symbol: MSLE) for the first time.
Investment bank Leerink Partners has initiated coverage on Satellos Bioscience Inc. (MSLE) with an "Outperform" rating and a $20 target price. This positive outlook by analysts highlights the biotechnology company's innovative technology platform. The report aims to provide professional research references for investors interested in Satellos Bioscience.